Quarterly Transactions Made in Spdr Ser Tr Spdr S&P Biotech E (XBI)
This table provides information about the institutional ownership of Spdr Ser Tr Spdr S&P Biotech E (XBI). The information is specifically focused on institutions that hold shares of SPDR SER TR SPDR S&P BIOTECH E.
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q1 2022 | 25,077,000 | 5,641,224 | 30,718,224 | 20,204,419 | 1,281,376 | 21,485,795 | 9,232,429 | |
Q2 2022 | 18,132,175 | 9,520,590 | 27,652,765 | 15,561,645 | 4,290,761 | 19,852,406 | 7,800,359 | |
Q3 2022 | 8,676,511 | 5,165,464 | 13,841,975 | 16,101,758 | 28,899 | 16,130,657 | -2,288,682 | |
Q4 2022 | 14,999,573 | 9,494,260 | 24,493,833 | 9,270,522 | 10,841 | 9,281,363 | 15,212,470 | |
Q1 2023 | 21,882,923 | 2,069,865 | 23,952,788 | 17,377,570 | 72 | 17,377,642 | 6,575,146 | |
Q2 2023 | 16,373,836 | 2,138,686 | 18,512,522 | 16,287,852 | 0 | 16,287,852 | 2,224,670 | |
Q3 2023 | 12,938,411 | 3,355,837 | 16,294,248 | 4,961,292 | 29,567 | 4,990,859 | 11,303,389 | |
Q4 2023 | 10,086,552 | 10,027,192 | 20,113,744 | 34,179,523 | 72 | 34,179,595 | -14,065,851 | |
Q1 2024 | 30,592,042 | 3,814,299 | 34,406,341 | 14,615,521 | 0 | 14,615,521 | 19,790,820 | |
Q2 2024 | 13,111,960 | 1,950,642 | 15,062,602 | 18,377,641 | 161,891 | 18,539,532 | -3,476,930 | |
Q3 2024 | 15,529,010 | 4,677,405 | 20,206,415 | 8,691,459 | 1 | 8,691,460 | 11,514,955 | |
Q4 2024 | 23,843,390 | 9,173,107 | 33,016,497 | 20,260,764 | 170,100 | 20,430,864 | 12,585,633 | |
Q1 2025 | 16,373,224 | 3,953,429 | 20,326,653 | 10,792,663 | 15,761 | 10,808,424 | 9,518,229 |